Net Cash Provided by (Used in) Financing Activities in USD of LEAP THERAPEUTICS, INC. from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Leap Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2016 to Q1 2025.
  • Leap Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$61K.
  • Leap Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $37.2M.
  • Leap Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$30K, a 85.7% increase from 2022.
  • Leap Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$210K, a 100% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

LEAP THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$61K -$90K Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $29K* +$58K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 -$29K* +$181K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 -$210K -$14.2M -102% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $14M -$11.6M -45.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $25.6M +$13.3M +108% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $12.3M -$2.68M -17.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $15M -$14.8M -49.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $29.8M Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-08-08

LEAP THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $37.2M +$37.2M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 -$30K +$180K +85.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 -$210K -$98.2M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $98M +$24M +32.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $74M +$59.2M +399% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $14.8M -$1.09M -6.85% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $15.9M -$31.9M -66.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $47.8M +$22.1M +86.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $25.6M Jan 1, 2016 Dec 31, 2016 10-K 2018-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.